Abcellera
Edit

Abcellera

http://www.abcellera.com/
Last activity: 24.05.2023
Categories: TechnologyPlatformDrugAutomation
Full-stack, AI-powered therapeutic antibody drug discovery platform
Website visits
35.9K /mo.
Mentions
33
Location: Canada, British Columbia, Vancouver
Employees: 501-1000
Total raised: $846.1M
Founded date: 2012

Investors 6

Funding Rounds 4

DateSeriesAmountInvestors
16.12.2020IPO$555.5M-
27.05.2020Series B$105M-
03.05.2020-$175.6M-
27.09.2018Series A$10M-

Mentions in press and media 33

DateTitleDescriptionSource
24.05.2023AbCellera receives $300 million in combined government fundi...-betakit.co...
08.11.2022“It’s not just about work.” – How (and why) to get a job at ...The How to get a job story series is supported by VanHack. Hire from VanHack’s 400K+ diverse tech ta...vantechjou...
11.08.2022AbCellera Partners With Atlas Venture to Discover Therapeuti...Vancouver, BC-based AbCellera (Nasdaq: ABCL) and Atlas Venture, a Cambridge, MA-based biotech ventur...finsmes.co...
10.08.2022Vancouver tech layoffs, talent, and hiring companiesAs the innovation economy comes under pressure, a number of local tech companies have been forced to...vantechjou...
15.12.2021Opinion: BC tech sector will roar even louder in 2022There’s no such thing as too much of a good thing. A case in point: The stellar year BC’s tech secto...vantechjou...
06.12.2021AbCellera’s antibody treatment becomes first to receive emer...Bamlanivimab, the antibody therapy discovered by Vancouver-based artificial intelligence (AI) biotec...betakit.co...
10.11.2021Ligand Pharma antibody spinoff plan sets up competition with...Antibodies are part of the wave of new biological drugs that are bringing new treatment options for ...medcitynew...
24.09.2021Cheatsheet: 69 BC firms make Globe and Mail’s top growing co...Two weeks ago Ravi Kahlon, BC’s minister of jobs, economic recovery and innovation, celebrated the A...vantechjou...
23.09.2021AbCellera and Everest Medicines Announce Multi-Target Collab...VANCOUVER, British Columbia and SHANGHAI, Sept. 23, 2021 /PRNewswire/ -- AbCellera (Nasdaq: ABCL) an...en.prnasia...
15.09.2021AbCellera Biologics : Acquisition expands AbCellera's existi...Acquisition expands AbCellera's existing capabilities to unlock difficult-to-drug transmembrane prot...marketscre...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In